RotaChrom Technologies

Executive Summary

RotaChrom Technologies, headquartered in Budapest, Hungary, is a private company specializing in silica-free, liquid–liquid centrifugal partition chromatography (CPC) purification solutions. Founded in 2013, the company addresses critical bottlenecks in downstream processing for small molecule and drug delivery applications. Unlike traditional silica-based chromatography, RotaChrom’s CPC platform eliminates the need for solid stationary phases, reducing costs, improving scalability, and simplifying regulatory compliance. Their systems seamlessly transition from process development to industrial production, adapting to changing capacity and purity requirements. This flexibility positions RotaChrom as a key enabler for biopharma manufacturers seeking efficient, cost-effective purification in an era of increasing demand for high-purity therapeutics. The company’s technology is particularly relevant for complex small molecules and novel drug delivery modalities where silica-based methods fall short. By offering a purely liquid-liquid system, RotaChrom minimizes solvent consumption, column fouling, and process downtime. With a focus on simplifying workflows, the company targets both established pharmaceutical companies and contract development and manufacturing organizations (CDMOs). As the biopharma industry shifts toward continuous manufacturing and flexible capacity, RotaChrom’s scalable CPC solutions are well-positioned to capture market share. While the company remains privately held and has not disclosed funding rounds, its innovative approach and growing adoption could drive significant value creation in the purification segment.

Upcoming Catalysts (preview)

• Q3 2026Strategic partnership with a major pharmaceutical company for CPC technology adoption65% success
• Q4 2026Launch of next-generation industrial-scale CPC system for continuous manufacturing70% success
• TBDRegulatory approval or qualification of CPC platform for GMP production80% success